<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="disorder (NMD) patients. The risk of a severe course of" exact="SARS-CoV-2 infection" post="is increased in all but the mildest forms of"/>
 <result pre="specific NMDs (metabolic, mitochondrial, myotonic diseases) and experimental approaches for" exact="Coronavirus disease 2019" post="may be offered â€œcompassionatelyâ€� only after consulting the patientâ€™s"/>
 <result pre="the lives of more than 400,000 individuals worldwide (https://coronavirus.jhu.edu/map.html). Symptomatic" exact="SARS-CoV-2 infection" post="causes a wide spectrum of symptoms (referred to as"/>
 <result pre="systemic manifestations in severe disease courses (Fig.Â 1). In parallel," exact="SARS-CoV-2 infection" post="poses a greater risk for old, oncologic, and immunosuppressed"/>
 <result pre="neurologic community facing common challenges. Fig. 1 Systemic involvement in" exact="SARS-CoV-2 infection." post="The figure shows the different organs and systems possibly"/>
 <result pre="to review the management of NMD patients with and without" exact="SARS-CoV-2 infection," post="focusing on COVID-19 therapies, COVID-19 drug-related complications, and ventilatory"/>
 <result pre="to neuromuscular disorders will probably encounter. The NMD patient without" exact="SARS-CoV-2 infection" post="Risk assessment and stratification Risk assessment and stratification are"/>
 <result pre="patients and families and their physicians to prevent and manage" exact="SARS-CoV-2 infection" post="in this category [6â€&quot;9]. Overall, these documents recognize that"/>
 <result pre="help to quickly identify NMD patients who suffered from severe" exact="SARS-CoV-2 infection" post="in other regions/states of the country and promptly manage"/>
 <result pre="of a neurologic examination at-distance comprises a suspected diagnosis of" exact="SARS-CoV-2 infection" post="in a young patient with Charcotâ€&quot;Marieâ€&quot;Tooth polyneuropathy undergoing post-surgical"/>
 <result pre="to which immunosuppressive drugs can contribute to severe forms of" exact="SARS-CoV-2 infection" post="is still unclear. Depending on the regional pandemic burden,"/>
 <result pre="Immunomodulant therapies currently used in NMD patients may help against" exact="SARS-CoV-2 infection." post="Some severe SARS-CoV-2 cases with acute respiratory insufficiency may"/>
 <result pre="home-delivery, and extending refill periods [42]. The NMD patient with" exact="SARS-CoV-2 infection" post="SARS-CoV-2 infection in NMD patients Clinical syndromes associated with"/>
 <result pre="extending refill periods [42]. The NMD patient with SARS-CoV-2 infection" exact="SARS-CoV-2 infection" post="in NMD patients Clinical syndromes associated with SARS-CoV-2 infection"/>
 <result pre="infection SARS-CoV-2 infection in NMD patients Clinical syndromes associated with" exact="SARS-CoV-2 infection" post="have been classified by the World Health Organization (WHO)"/>
 <result pre="and septic shock [7]. In case of symptoms suggestive for" exact="SARS-CoV-2 infection," post="NMD patients should follow local health authorities' policies, call"/>
 <result pre="on the clinical course and recovery of NMD patients with" exact="SARS-CoV-2 infection." post="A small case series of 5 immunosuppressed MG patients"/>
 <result pre="has been approved (Table 3). Table 3 Experimental treatments for" exact="SARS-CoV-2 infection" post="Drug Results so far Potential NMD-relevant side effects Chloroquine"/>
 <result pre="is a novel nucleotide analogue developed for the treatment of" exact="Ebola" post="and Marburg viruses. Remdesivir was shown to have in"/>
 <result pre="outcome was favourable. Overall, the literature on NMD patients with" exact="SARS-CoV-2 infection" post="is limited in number and general considerations are difficult."/>
 <result pre="literature regarding the management of NMD patients with and without" exact="SARS-CoV-2 infection," post="addressing the concerns and challenges on the recommendations on"/>
 <result pre="guidance. https://apps-who-int.pros.lib.unimi.it:2050/iris/handle/10665/330854. Accessed 26 Apr 2020 8.World Muscle Society (2020)" exact="Covid-19" post="and people with neuromuscular disorders: World Muscle Society position"/>
 <result pre="Allergy Clin Immunol202010.1016/j.jaip.2020.04.00332169379 16.MaoLJinHWangMHuYChenSHeQet al.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA Neurol201910.1001/jamaneurol.2020.1127 17.Toscano G, Palmerini F, Ravaglia"/>
 <result pre="53.ArabiYMArifiAABalkhyHHNajmHAldawoodASGhabashiAet al.Clinical course and outcomes of critically ill patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAnn Intern Med201416038939724474051 54.Hui DS, Chow BK, Lo"/>
</results>
